For the next few weeks, what needs to be watched is market breadth. And also look at which sectors are leading the rally. Why? Because, at ...

Global financial markets are experiencing a risk-off shift driven by rising sovereign bond yields, impacting equities and commodities. Mark...

The United States is accelerating research into psychedelic drugs for mental illness. This shift prompts India to re-evaluate its own drug ...

SUSE plans to increase investments in India, recognizing it as a significant growth market for open-source technologies. The company aims t...

Emkay Investment Managers' Kashyap Javeri believes India's sovereign rating upgrade and inclusion in global bond indices will attract signi...

Abu Dhabi's Mubadala Investment Company plans to expand in India's healthcare sector, seeking deals in the $200-500 million range. With a f...

“ HDFC Bank is a very good long-term and a slightly medium-term play. I do not rule out Bank Nifty going back to test 46,000 in this month ...

ADIA, with assets under management worth $800 billion, has a wide exposure in India. Its major investments include Flipkart, Reliance Retai...

As per RDIF, Sputnik Light has been authorized in more than 15 countries. Gland Pharma said it is focusing on rolling out the single shot S...

Vitane Biologics, with around 100 personnel, has a dedicated research and development facility and a manufacturing plant to handle both mic...

“We understand that the government needs to use the public health safeguards in the Patents Act and permit more companies to produce these ...

Modi will chair the Virtual Global Investor Roundtable (VGIR) that will also see participation from domestic industry.

Opportunity to launch a vaccine would mean one-time exceptional business gain, brand boost

"We are proud to commercially launch Cipremi today (on Wednesday); amongst the lowest priced globally, and aim to supply over 80,000 vials ...

The recommended course for a Covid-19 patient under oxygen support is five vials. The approved therapy is for moderate to severe patients.

Indoco’s domestic formulations sales for the year ended March 31, 2018, were flat at Rs 595 crore, as against Rs 585 crore last year (growt...

“The size of the bond issuance is expected to be in the range of $500-1,000 million with five- to 10-year maturities, depending on its pric...